Discover 1,604 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,604
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: Aurora CO, Salt Lake City UT, Tucson AZ, Dallas TX,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase 1, Phase 2, Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for
Small Cell Lung Cancer Extensive Stage
Location: Aurora CO, Sioux Falls SD, St Louis MO, Memphis TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227597
Phase 1, Phase 2, Recruiting
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
for
AML, Adult, MDS
Location: Aurora CO, St Louis MO, Duarte CA, Houston TX,
Sponsor: Stelexis BioSciences
Sex: All
Age: 18+
Code: NCT06533761
Phase 1, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Location: Aurora CO, Oklahoma City OK, Boston MA, Weymouth MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT06366347
Phase 2, Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Aurora CO, Newport Beach CA, Los Angeles CA, Houston TX,
Sponsor: Volastra Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05902988
Phase 1, Phase 2, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Aurora CO, West Valley City UT, Oklahoma City OK,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase 1, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Aurora CO, Omaha NE, Rochester MN, Iowa City IA,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase 3, Recruiting
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Aurora CO, Denver CO, Las Vegas NV, Irving TX,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06384352
Phase 1, Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Aurora CO, Omaha NE, Tucson AZ, Peoria IL, Spokane WA,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
Specimen Banking From Patients With Lung Cancer
for
Lung Neoplasms
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT01585675
Recruiting
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
for
Carcinoma, Squamous Cell
Location: Aurora CO, Dallas TX, Louisville KY, Columbia SC,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041613
Phase 3, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Aurora CO, Denver CO, Salt Lake City UT, Wichita KS,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Aurora CO, Tulsa OK, Las Vegas NV, Tucson AZ, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase 3, Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
for
Advanced Lung Cancer
Location: Aurora CO, Phoenix AZ, Dallas TX, Rochester MN,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06892548
Phase 1, Phase 2, Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for
Uterine Fibroids, Endometriosis
Location: Aurora CO, Greenwood Village CO, Lakewood CO,
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female
Age: 18 - 50
Code: NCT05862272
Phase 3, Recruiting
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor